Aptevo Therapeutics Inc. APVO
1.14 USD -0.10 (-8.06%)
Nov 9, 2026, 11:08 AM EST
1.13 Day range 1.22
1.07 52-week range 28.08
- YTD
- -87.91%
- 1 year
- -95.69%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 26.31M | 24.60M | 28.88M | 31.75M | 33.69M | |
| 14.54M | 14.38M | 17.11M | 17.88M | 18.99M | |
| 11.77M | 10.22M | 11.77M | 13.87M | 14.70M | |
| -26.31M | -24.60M | -28.88M | -28.64M | -21.40M | |
| -25.97M | -24.13M | -17.41M | 8.03M | -28.46M | |
| -27.54M | -24.13M | -17.41M | 8.03M | -28.46M | |
| -27.54M | -24.13M | -17.41M | 8.03M | -28.46M | |
| -25.97M | -24.13M | -17.41M | 8.03M | -28.46M | |
| -87.27 | -31,460.23 | -834,059.00 | 920,146.00 | -3,557,506.00 | |
| -87.27 | -31,460.23 | -834,059.00 | 920,146.00 | -3,557,506.00 | |
| -87.27 | -31,460.23 | -834,059.00 | 920,146.00 | -3,557,506.00 | |
| -25.97M | -24.13M | -17.41M | 8.03M | -28.46M | |
| -25.97M | -24.13M | -17.41M | 8.03M | -28.46M | |
| 1.57M | 0 | 0 | 0 | 0 | |
| 315.54K | 767 | 21 | 9 | 8 | |
| 315.54K | 767 | 21 | 9 | 8 |